DE3869444D1 - D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. - Google Patents

D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Info

Publication number
DE3869444D1
DE3869444D1 DE8888300710T DE3869444T DE3869444D1 DE 3869444 D1 DE3869444 D1 DE 3869444D1 DE 8888300710 T DE8888300710 T DE 8888300710T DE 3869444 T DE3869444 T DE 3869444T DE 3869444 D1 DE3869444 D1 DE 3869444D1
Authority
DE
Germany
Prior art keywords
prostaglandine
tranquilizers
hypnotics
soporifics
pgds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888300710T
Other languages
German (de)
English (en)
Inventor
Ryuzo Ueno
Ryuji Ueno
Ichie Kato
Tomio Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Application granted granted Critical
Publication of DE3869444D1 publication Critical patent/DE3869444D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8888300710T 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. Expired - Lifetime DE3869444D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1882187 1987-01-28

Publications (1)

Publication Number Publication Date
DE3869444D1 true DE3869444D1 (de) 1992-04-30

Family

ID=11982228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888300710T Expired - Lifetime DE3869444D1 (de) 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Country Status (8)

Country Link
US (3) US5073569A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0281239B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR930006201B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE74126T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1322749C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3869444D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2032956T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3004281T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
EP0455264B1 (en) * 1987-09-18 1994-07-13 R-Tech Ueno Ltd. Ocular hypotensive agents
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1224935A3 (en) 1988-09-06 2003-03-26 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
DE69019431T2 (de) * 1989-07-27 1995-09-14 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
ATE121624T1 (de) * 1989-08-09 1995-05-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von prostansäurederivaten zur herstellung von arzneimitteln zur verbesserung der ausscheidung von nichtprotein in die därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
TW249226B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK0503887T3 (da) * 1991-03-14 1996-09-16 R Tech Ueno Ltd Fremme af sårheling med 15-ketoprostaglandinforbindelser
AU742232B2 (en) 1998-05-25 2001-12-20 Fumie Sato Sleep-Inducing Preparation
DE60138371D1 (de) 2000-03-24 2009-05-28 Sucampo Ag PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis
NZ521784A (en) * 2000-04-06 2005-04-29 Sucampo Ag Bile secretion promoting composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
NZ531503A (en) 2001-08-31 2006-01-27 Sucampo Ag Prostaglandin analogs as chloride channel opener
CA2502439C (en) * 2002-10-23 2011-11-22 Sucampo Ag Prostaglandin compounds for the treatment of obesity
MXPA05006981A (es) 2002-12-27 2005-12-14 Sucampo Ag Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
EP1641462B1 (en) * 2003-07-03 2010-11-24 Sucampo AG Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
KR101118935B1 (ko) 2003-08-21 2012-03-13 가부시키가이샤 아루떼꾸 우에노 안과용 조성물
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
WO2006080549A2 (en) 2005-01-27 2006-08-03 Sucampo Ag Method and composition for treating central nervous system disorders
EP2308495A1 (en) 2005-03-04 2011-04-13 Sucampo AG Method and composition for treating peripheral vascular diseases
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
PT1871380E (pt) * 2005-04-12 2011-11-21 Sucampo Ag Utilização combinada de composto de prostaglandina e inibidor de bomba de protões para o tratamento de distúrbios gastrointestinais
KR101465269B1 (ko) 2006-01-24 2014-11-26 가부시키가이샤 아루떼꾸 우에노 바이-사이클릭 화합물을 함유하는 약학적 조성물 및 바이-사이클릭 화합물의 안정화 방법
AU2007208632B2 (en) 2006-01-24 2012-01-19 R-Tech Ueno, Ltd. Soft-gelatin capsule formulation
WO2007105691A1 (ja) * 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
US8871752B2 (en) 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
KR20140035363A (ko) 2011-04-07 2014-03-21 수캄포 아게 안정피로 치료 방법
MX359697B (es) 2011-08-05 2018-10-08 Sucampo Ag Metodo para tratar esquizofrenia.
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
AR105029A1 (es) 2015-06-19 2017-08-30 Sucampo Ag Composición farmacéutica que comprende derivado de ácido graso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
EP0455264B1 (en) * 1987-09-18 1994-07-13 R-Tech Ueno Ltd. Ocular hypotensive agents

Also Published As

Publication number Publication date
EP0281239B1 (en) 1992-03-25
KR880008986A (ko) 1988-09-13
US5534547A (en) 1996-07-09
US5073569A (en) 1991-12-17
ES2032956T3 (es) 1993-03-01
CA1322749C (en) 1993-10-05
GR3004281T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-31
EP0281239A2 (en) 1988-09-07
EP0281239A3 (en) 1988-09-21
US5137915A (en) 1992-08-11
ATE74126T1 (de) 1992-04-15
KR930006201B1 (ko) 1993-07-08

Similar Documents

Publication Publication Date Title
DE3869444D1 (de) D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE69009636D1 (de) Belastungsregelung und Verfahren.
DE3853191D1 (de) Arzneimittelträger.
DE3887830D1 (de) Viskoelastische Reinigungsmittel und deren Anwendung.
ATE82574T1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
DE59004453D1 (de) Farbstoffmischung und deren Verwendung.
ATE105297T1 (de) Derivate von 2'-halomethyliden, 2'-ethenyliden und 2'-ethynylcytidin, uridin und guanosin.
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
DE69010141D1 (de) Lager und Lageranordnung.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
DE68917352D1 (de) Trimethylolheptane und ihre Anwendung.
DE3684700D1 (de) Hochfunktionelle fluorierte polyisocyanate und daraus hergestellte klarlacke.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
DE3789963D1 (de) Menschliche tachykinine und ihre vorläufer.
PT85396B (de) Neue 1,4-benzodiazepine ihre herstellung und verwendung
DE3783751D1 (de) Glyzirrhetinsaeure-derivate und ihre anwendung.
DE3689919D1 (de) Polyfluorisoxazolamine, ihre Herstellung und Anwendung.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
DE69012298D1 (de) Heizen von Lagern und dergleichen.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE96142T1 (de) Triglyceridquartaerammonium-verbindungen, ihre herstellung und anwendung.
DE3880307D1 (de) Perfluoralkene und fluorierungsprodukte davon.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH